Literature DB >> 21324802

Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival.

Sergej Osinsky1, Larissa Bubnovskaya, Irina Ganusevich, Antonina Kovelskaya, Lilya Gumenyuk, Gennadij Olijnichenko, Sergej Merentsev.   

Abstract

INTRODUCTION: Hypoxia is a key feature of the microenvironment of cancer cells actively participating in tumour progression. Our study was aimed to evaluate the impact of hypoxia and hypoxia-associated factors on tumour progression and survival of patients with gastric cancer.
MATERIAL AND METHODS: One hundred and five resected specimens were used. The level of tumour hypoxia was evaluated using (31)P NMR spectroscopy, CD68 (tumour-associated macrophages), CD34 (microvessel density, MVD) and VEGF expression, immunohistochemistry, MMP-2 and MMP-9 activity, zymography. Statistical analysis was conducted using Pearson's test, Kaplan-Meier survival analysis, log-rank test and Cox proportional hazards model.
RESULTS: Intratumoral hypoxia level has been significantly correlated with VEGF expression, TAM number and total protease activity. The overall survival rate of patients with strong tumour hypoxia, high level of MVD, VEGF expression, TAM and MMP activity was significantly lower than that of the patients without the mentioned tumour characteristics.
CONCLUSIONS: The hypoxia-associated signalling that is activated in tumours promotes tumour progression through the recruitment of macrophages, remodelling of extracellular matrix and neoangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324802     DOI: 10.1007/s12094-011-0630-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  25 in total

Review 1.  Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Authors:  James L Tatum; Gary J Kelloff; Robert J Gillies; Jeffrey M Arbeit; J Martin Brown; K S Clifford Chao; J Donald Chapman; William C Eckelman; Anthony W Fyles; Amato J Giaccia; Richard P Hill; Cameron J Koch; Murali Cherukuri Krishna; Kenneth A Krohn; Jason S Lewis; Ralph P Mason; Giovanni Melillo; Anwar R Padhani; Garth Powis; Joseph G Rajendran; Richard Reba; Simon P Robinson; Gregg L Semenza; Harold M Swartz; Peter Vaupel; David Yang; Barbara Croft; John Hoffman; Guoying Liu; Helen Stone; Daniel Sullivan
Journal:  Int J Radiat Biol       Date:  2006-10       Impact factor: 2.694

Review 2.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

3.  Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.

Authors:  Li Zhang; Zhong-Sheng Zhao; Guo-Qing Ru; Jie Ma
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

4.  Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer.

Authors:  A Fyles; M Milosevic; D Hedley; M Pintilie; W Levin; L Manchul; R P Hill
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

5.  Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.

Authors:  Wei Hao Sun; Yun Liang Sun; Ren Nian Fang; Yun Shao; Hai Chen Xu; Qi Ping Xue; Guo Xian Ding; Yun Lin Cheng
Journal:  Jpn J Clin Oncol       Date:  2005-11-28       Impact factor: 3.019

6.  Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas.

Authors:  Ken Mizokami; Yoshihiro Kakeji; Shinya Oda; Koji Irie; Tomohiro Yonemura; Fumio Konishi; Yoshihiko Maehara
Journal:  J Surg Oncol       Date:  2006-08-01       Impact factor: 3.454

Review 7.  Gastric cancer.

Authors:  Vincenzo Catalano; Roberto Labianca; Giordano D Beretta; Gemma Gatta; Filippo de Braud; Eric Van Cutsem
Journal:  Crit Rev Oncol Hematol       Date:  2009-02-20       Impact factor: 6.312

8.  Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas.

Authors:  Jin-Rong Du; Ying Jiang; Yan-Mei Zhang; Hong Fu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

9.  Tumor-associated macrophages press the angiogenic switch in breast cancer.

Authors:  Elaine Y Lin; Jeffrey W Pollard
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

10.  Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.

Authors:  F J G M Kubben; C F M Sier; W van Duijn; G Griffioen; R Hanemaaijer; C J H van de Velde; J H J M van Krieken; C B H W Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

View more
  30 in total

1.  Overexpression of the HIF hydroxylase PHD3 is a favorable prognosticator for gastric cancer.

Authors:  Changlei Su; Kejin Huang; Lingyu Sun; Dongdong Yang; Hongqun Zheng; Changlu Gao; Jinxue Tong; Qifan Zhang
Journal:  Med Oncol       Date:  2012-12       Impact factor: 3.064

2.  Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3.

Authors:  Bibo Tan; Yong Li; Qun Zhao; Liqiao Fan; Dong Wang; Yü Liu
Journal:  Tumour Biol       Date:  2013-09-27

3.  Tumor-associated macrophages in osteosarcoma.

Authors:  Yi Zhao; Benzheng Zhang; Qianqian Zhang; Xiaowei Ma; Helin Feng
Journal:  J Zhejiang Univ Sci B       Date:  2021-11-15       Impact factor: 3.066

4.  Targeting tumor microenvironment: the key role of immune system.

Authors:  Jaleh Barar
Journal:  Bioimpacts       Date:  2012-03-13

5.  Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer.

Authors:  Pedro Villarejo-Campos; David Padilla-Valverde; Raúl Martin Martin; Pablo Menéndez-Sánchez; Teófilo Cubo-Cintas; Jose Antonio Bondia-Navarro; Jesús Martín Fernández
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

6.  Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages.

Authors:  Pan Su; Qiang Wang; Enguang Bi; Xingzhe Ma; Lintao Liu; Maojie Yang; Jianfei Qian; Qing Yi
Journal:  Cancer Res       Date:  2020-02-03       Impact factor: 12.701

Review 7.  Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers.

Authors:  Ross King; Conall Hayes; Claire L Donohoe; Margaret R Dunne; Maria Davern; Noel E Donlon
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

Review 8.  New insights into M1/M2 macrophages: key modulators in cancer progression.

Authors:  Jiuyang Liu; Xiafei Geng; Jinxuan Hou; Gaosong Wu
Journal:  Cancer Cell Int       Date:  2021-07-21       Impact factor: 5.722

9.  Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses.

Authors:  Qiaoyun Shi; Laura J Pisani; Yauk K Lee; Solomon Messing; Celina Ansari; Srabani Bhaumik; Lisa Lowery; Brian D Lee; Dan E Meyer; Heike E Daldrup-Link
Journal:  Contrast Media Mol Imaging       Date:  2013 May-Jun       Impact factor: 3.161

10.  Angiogenesis and lymphangiogenesis as prognostic factors after therapy in patients with cervical cancer.

Authors:  Marta Biedka; Roman Makarewicz; Ewa Kopczyńska; Andrzej Marszałek; Alina Goralewska; Hanna Kardymowicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.